Analysts have been eager to weigh in on the Healthcare sector with new ratings on Joint (JYNT – Research Report) and Cerus (CERS – Research Report).
Joint (JYNT)
In a report released today, Jeremy Hamblin from Craig-Hallum reiterated a Hold rating on Joint, with a price target of $10.50. The company’s shares closed last Thursday at $12.86.
According to TipRanks.com, Hamblin is a 4-star analyst with an average return of
Currently, the analyst consensus on Joint is a Moderate Buy with an average price target of $13.83.
See Insiders’ Hot Stocks on TipRanks >>
Cerus (CERS)
In a report released today, William Bonello from Craig-Hallum maintained a Buy rating on Cerus, with a price target of $5.00. The company’s shares closed last Thursday at $1.76.
According to TipRanks.com, Bonello is a 5-star analyst with an average return of
Currently, the analyst consensus on Cerus is a Strong Buy with an average price target of $5.00, representing a 190.7% upside. In a report released today, Cantor Fitzgerald also maintained a Buy rating on the stock with a $4.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on JYNT:
- Joint Corp Earnings Presentation and Upcoming Call
- The Joint Corp. to Host Conference Call on Thursday, May 2nd to Discuss First Quarter 2024 Results
- Joint Corp participates in a conference call with Lake Street
- Sportsman’s Warehouse names Krischelle Tennessen CHRO, Michael Simpson CIO
- Joint Corp Is Worried About This – Should You Be Worried Too?
